A recent study by scientists at the Wertheim UF Scripps Institute for Biomedical Innovation & Technology has found that the common amino acid glycine may contribute to major depression, anxiety, and other mood disorders by delivering a “slow-down” signal to the brain. The discovery improves our understanding of the biological causes of major depression and could accelerate efforts to develop new and faster-acting medications for such hard-to-treat mood disorders. While the research is still in its early stages, the findings provide valuable insights into the role played by glycine in mood disorders, and hopefully, pave the way for new treatments that can offer more immediate benefits to individuals suffering from depression and other related conditions.
Dr Sophia Hughes, MD, Cure of Mind